Dividend-adjusted total return · S&P 500 uses VOO · Nov 4, 2025 – Nov 5, 2026HRTSS&P 500 · VOO
| Returns | 1D | 1M | 3M | YTD | 1Y | 3Y | 5Y | MAX |
|---|---|---|---|---|---|---|---|---|
| Total return | −3.4% | +7.0% | +3.2% | +9.0% | +20.4% | — | — | +48.6% |
| S&P 500 · VOO | −4.4% | −5.7% | −4.9% | +8.4% | +9.8% | +82.2% | +71.6% | — |
Key Statistics
Open all fund facts →- AUM
- $57M
- Expense ratio
- 0.99%
- Distribution yield
- 1.2%
- NAV
- $38.67
- Volume
- 6K
- Avg. volume 30D
- 2K
- High today
- $39.75
- Low today
- $38.47
- Previous close
- $39.84
- 52-week high
- $39.92
- 52-week low
- $32.12
- Our risk indicator
- 4/5
HRTS in One Breath
HRTS Among Its Peers
YTDEnd-of-day Nov 6, 2026 · 1 ETFs by YTD
$10,000 in HRTS
5Y$10,000 in HRTS became
$14,859
In the S&P 500 (VOO)
$16,816
Total return, dividends in · Nov 21, 2023 – Nov 5, 2026 · S&P 500 uses VOO
HRTS’s Top Holdings
TodayLLYEli Lilly &12.5%TMO5.2%MRK4.4%RHHBY4.3%RVMD3.6%KOD3.6%BBIO3.6%GILD3.4%UNH3.3%AZN.L3.2%NOVN.SW3.1%DHR3.1%NOVO-B.CO3.0%ABT3.0%JNJ3.0%CYTK3.0%VRTX2.8%ISRG2.6%MDT2.3%MCK2.1%SYK2.1%CNC25 more
LLYEli Lilly &12.5%TMO5.2%MRK4.4%RHHBY4.3%RVMD3.6%KOD3.6%BBIO3.6%GILD3.4%UNH3.3%AZN.L3.2%NOVN.SW3.1%DHR3.1%35 more
Drug Manufacturers - GeneralBiotechnologyMedical - DevicesMedical - DiagnosticsMedical - Healthcare PlansMedical - InstrumentsOther
Tema HRTS · 47 holdings · tile size = share of the fund · as of Nov 5, 2026
What HRTS Holds
TodayDrug Manufacturers - General43.2%
LLY 12.5 · MRK 4.4 · RHHBY 4.3 · GILD 3.4 · AZN.L 3.2 · NOVN.SW 3.1 · NOVO-B.CO 3.0
Biotechnology23.0%
RVMD 3.6 · KOD 3.6 · BBIO 3.6 · CYTK 3.0 · VRTX 2.8 · REGN 1.2 · STOK
Medical - Devices12.4%
ABT 3.0 · MDT 2.3 · SYK 2.1 · EW 1.4 · DXCM 1.3 · BSX 1.2 · PODD
Medical - Diagnostics & Research9.4%
TMO 5.2 · DHR 3.1 · ILMN 1.0
Medical - Healthcare Plans5.4%
UNH 3.3 · CNC 2.1
Medical - Instruments & Supplies2.6%
ISRG 2.6
Medical - Distribution2.1%
MCK 2.1
Tema HRTS · share of the fund by industry · as of Nov 5, 2026
Eli’s Share of HRTS
Today12.5%
$125 of every $1,000 in HRTS is Eli
Eli held by HRTS
$7.1M
Tema HRTS · each square = $10 of $1,000 · as of Nov 5, 2026
HRTS’s Size vs Its Peers
Today$57.2Mthe largest ETF
AUM · HRTS and the 0 largest peers · Nov 6, 2026
HRTS Fee per $100 vs Peers
TodayExpense ratio · peers · Nov 6, 2026
Inside HRTS
47 holdings · as of Nov 5, 2026HRTS
Tema Heart & Health ETF
TodayDrug Manufacturers - General43.2%LLY12.5%MRK4.4%RHHBY4.3%GILD3.4%AZN.L3.2%NOVN.SW3.1%NOVO-B.CO3.0%JNJ3.0%ABBVBMYAMGNBiotechnology23.0%RVMD3.6%KOD3.6%BBIO3.6%CYTK3.0%VRTX2.8%REGNSTOKMDGLGMABXENEARWRSRRKMBXVKTXMedical - Devices12.4%ABT3.0%MDT2.3%SYK2.1%EWDXCMBSXPODDSOON.Medical - Diagnostics9.4%TMO5.2%DHR3.1%ILMNMedical - Healthcare Plans5.4%UNH3.3%CNCMedical - Instruments2.6%ISRGMCKTEVACTY
| # | Ticker | Company | Weight ▼ |
|---|---|---|---|
| 1 | LLY | ELI Lilly & | 12.48% |
| 2 | TMO | Thermo Fisher Scientific | 5.25% |
| 3 | MRK | Merck & | 4.40% |
| 4 | RHHBY | Roche AG | 4.26% |
| 5 | RVMD | Revolution Medicines | 3.61% |
| 6 | KOD | Kodiak Sciences | 3.61% |
| 7 | BBIO | Bridgebio Pharma | 3.60% |
| 8 | GILD | Gilead Sciences | 3.45% |
| 9 | UNH | Unitedhealth Group | 3.29% |
| 10 | AZN.L | Astrazeneca | 3.17% |
Drug Manufacturers - GeneralBiotechnologyMedical - DevicesMedical - DiagnosticsMedical - Healthcare PlansMedical - InstrumentsMedical - DistributionDrug Manufacturers - SpecialtyOther
Tema HRTS · current holdings by weight · as of Nov 5, 2026 · each tile is one holding · top 20 = 75.2%
All HRTS Holdings
47 holdings · as of Nov 5, 2026 →HRTS
HRTS’ Holdings
Top 15 by weight| # | Per $1,000 | |||||
|---|---|---|---|---|---|---|
| 1 | LLYELI Lilly | Healthcare | 12.48% | $124.85 | 5,191 | $7.4M |
| 2 | TMOThermo Fisher Scientific | Healthcare | 5.25% | $52.47 | 4,381 | $3.1M |
| 3 | MRKMerck | Healthcare | 4.40% | $44.02 | 17K | $2.6M |
| 4 | RHHBYRoche AG | Healthcare | 4.26% | $42.61 | 41K | $2.5M |
| 5 | RVMDRevolution Medicines | Healthcare | 3.61% | $36.12 | 11K | $2.1M |
| 6 | KODKodiak Sciences | Healthcare | 3.61% | $36.11 | 22K | $2.1M |
| 7 | BBIOBridgebio Pharma | Healthcare | 3.60% | $36.00 | 27K | $2.1M |
| 8 | GILDGilead Sciences | Healthcare | 3.45% | $34.46 | 12K | $2.0M |
| 9 | UNHUnitedhealth Group | Healthcare | 3.29% | $32.87 | 4,734 | $1.9M |
| 10 | AZN.LAstrazeneca | Healthcare | 3.17% | $31.73 | 9,903 | $1.9M |
| 11 | NOVN.SWNovartis AG | Healthcare | 3.08% | $30.79 | 11K | $1.8M |
| 12 | DHRDanaher | Healthcare | 3.07% | $30.70 | 7,704 | $1.8M |
| 13 | NOVO-B.CONovo Nordisk A/S | Healthcare | 3.05% | $30.48 | 42K | $1.8M |
| 14 | ABTAbbott Laboratories | Healthcare | 3.04% | $30.36 | 15K | $1.8M |
| 15 | JNJJohnson & Johnson | Healthcare | 2.99% | $29.91 | 6,382 | $1.8M |
Tema HRTS · per $ = dollars of each holding in that stake · as of Nov 5, 2026
How It Compares
HRTS
Tema Heart & Health ETF’s Peers
YTDHRTS has no close peers in our data yet: […]
Similar peers · YTD and past-year returns · as of Nov 6, 2026 · sorted by AUM
Head to Head
HRTS vs VOO
YTDHRTS · Tema Heart & Health
+9.0%
VOO · S&P 500
+8.4%
Gap
0.6 pts
Tema HRTS and Vanguard VOO · YTD total return · as of Nov 6, 2026
HRTS vs Its Peer Average
YTDHRTSAvsBPeer average
1D−3.4%[…]
1M+7.0%[…]
3M+3.2%[…]
YTD+9.0%[…]
1Y+20.4%[…]
0–0level
0 peers · each row scaled to its leader
The Details
HRTS
Risk
1Y4/5our risk indicator
CalmerBumpier
Volatility · 1Y17.23%
Deepest drop · 1Y−11.0%
Lowest point · 5Y0.0%
52-week range
$38.47
$32.12−3.6% from the high$39.92
Tema HRTS · past-year price moves · as of Nov 6, 2026
HRTS
Fund Facts
Today2023launched Nov 20
Tracks[…]
Exchange · CUSIPNASDAQ · 87975E883
StructureETF
Leverage1x
Cost on $10,000$99 a year
Go deeper
Tema HRTS · fund facts · as of Nov 6, 2026
HRTS
Payouts by Year
2Y$0.47per share, Dec 2025
Distribution yield1.2%
Paid[…]
Latest ex-date · paidDec 10 · Dec 11, 2025
2 payouts added up$0.94 a share
Tema HRTS · distributions by ex-date · 2024–2025
All Fund FactsDocuments · trading · fees · every payout
Prospectus & Documents
SEC reported portfolio · 2026-08-31 ↗SEC reported portfolio · 2026-05-31 ↗summary prospectus · SEC 497K ↗SEC reported portfolio · 2026-02-28 ↗summary prospectus · SEC 497K ↗SEC reported portfolio · 2025-11-30 ↗SEC reported portfolio · 2025-08-31 ↗SEC reported portfolio · 2025-05-31 ↗summary prospectus · SEC 497K ↗SEC reported portfolio · 2025-02-28 ↗SEC reported portfolio · 2024-11-30 ↗summary prospectus · SEC 497K ↗SEC reported portfolio · 2024-08-31 ↗SEC reported portfolio · 2024-05-31 ↗summary prospectus · SEC 497K ↗SEC reported portfolio · 2024-02-29 ↗summary prospectus · SEC 497K ↗SEC reported portfolio · 2023-11-30 ↗summary prospectus · SEC 497K ↗
Trading & Liquidity
Net asset value$38.67
Premium / discount[…]
Median spread · 30D[…]
Volume today6K
Average volume · 30D2K
Shares outstanding[…]
Options[…]
Fees & Costs
Net expense ratio0.99%
Gross expense ratio[…]
Management fee[…]
Cost on $10,000 a year$99.00
Our risk indicator4/5
Estimated yearly cost excludes trading costs and assumes constant assets.
Distributions
| Ex-date | Paid | Per share |
|---|---|---|
| Dec 10, 2025 | Dec 11, 2025 | $0.47 |
| Dec 11, 2024 | Dec 12, 2024 | $0.47 |
Issuer contentFrom TemaHear the strategy from the people behind HRTS.No issuer videos have been published for this fund.Are you the issuer? Claim this fund →